You are here: Industry Insights > Market News

News List

FDA approves Trulance for Chronic Idiopathic Constipation FDA
January 22, 2017
The U.S. Food and Drug Administration today approved Trulance (plecanatide) for the treatment of Chronic Idiopathic Constipation (CIC) in adult patients.
UCB, Dermira plan psoriasis filing for Cimzia in Q3 pharmatimes
January 20, 2017
UCB and Dermira are expecting to file anti-inflammatory Cimzia for psoriasis in the third quarter of this year, after the drug's strong performance in a late-stage trial involving patients with severe chronic plaque forms of the skin disease.
GSK snatches AZ Europe VP to replace exiting global head of pharma pharmafile
January 20, 2017
GlaxoSmithKline has announced that its global head of pharmaceuticals Abbas Hussain (pictured) is leaving the company; the vacated role will then be filled by AstraZeneca’s vice president of European business Luke Miels.
Eli Lilly to aquire pain biotech CoLucid for $960 million europeanpharmaceuticalreview
January 20, 2017
Eli Lilly and Company will acquire CoLucid Pharmaceuticals for $46.50 per share or approximately $960 million. This all-cash transaction will enhance Lilly’s existing portfolio in pain management for migraine, while adding a potential near-term launch to
EU approval for c’s type 2 diabetes treatment europeanpharmaceuticalreview
January 20, 2017
The European Commission (EC) has granted marketing authorisation in Europe for Sanofi‘s Suliqua, a titratable fixed-ratio combination of basal insulin glargine 100 Units/mL and GLP-1 receptor agonist lixisenatide for the treatment of adults with type 2 di
Panacea initiates Phase I prostate cancer vaccine therapy trial europeanpharmaceuticalreview
January 20, 2017
Panacea Pharmaceuticals have enrolled and dosed the first patient in the open-label, parallel designed, multi-centre Phase I clinical trial of PAN-301-1, for the treatment of persistent prostate cancer to assess safety and immunogenicity.
Osteoarthritis – opportunity analysis and forecasts to 2024 pharmaasia
January 20, 2017
Rapid growth in the Osteoarthritis (OA) market within the seven major markets is expected by 2024.
Better early nutrition, better brains: Study discusses model for understanding nutrition and brain d worldpharmanews
January 20, 2017
Pediatric nutrition research has shown the important effects of early-life nutrition on a baby’s development - especially the gastrointestinal tract - and more recent research indicates that nutrition may also have an influence on an infant’s brain as it
Boehringer Ingelheim biosimilar candidate to Humira accepted for EMA and FDA regulatory review worldpharmanews
January 20, 2017
Boehringer Ingelheim announced that BI 695501, its adalimumab biosimilar candidate to Humira®*, has been accepted for regulatory review by the European Medicines Agency (EMA) and the U.S Food and Drug Administration (FDA).
Evotec, Asahi Kasei Enter Drug Discovery Collaboration contractpharma
January 20, 2017
Evotec will apply its integrated drug discovery platform to optimize hit compounds